Mesenchymal stem cells (MSCs) show immunoregulatory properties. Here, we compared MSCs obtained from placenta (P-MSCs) and umbilical cord (C-MSCs) from the same donor, for their immunomodulatory efficacy. P-MSCs and C-MSCs showed similar morphology and phenotypic profile, but different clonogenic ability. Importantly, they showed a significant difference in their immunosuppressive properties as assessed in mixed leukocyte reaction (MLR). The P-MSCs affected the antigen presenting ability of mononuclear cells (MNCs) and dendritic cells (DCs) significantly as compared to C-MSCs resulting in a reduced T-cell proliferation. P-MSC conditioned medium (CM) showed a significant reduction in T cell proliferation as compared to C-MSC CM, thus suggesting that a cell to cell contact is not essential. We found increased levels of IL-10 and TGFβ1 and reduction in levels of IFNγ in P-MSC MLRs as compared to C-MSC MLRs. Furthermore, the CD3 + CD4 + CD25 + T regulatory cells were enriched in case of P-MSCs in both, MSC-MNC and MSC-DC co-cultures. This observation was further supported by increased mRNA expression of FoxP3 in P-MSCs. Presently, cord-derived MSCs are being employed in transplantation therapies parallel to the bone marrowderived MSCs. Our findings suggest that P-MSCs can be a better alternative to C-MSCs, to provide aid in immunological ailments.
Scientific RepoRts | 5:15784 | DOi: 10.1038/srep15784 models of multiple sclerosis 6, 7 and rheumatoid arthritis 8, 9 , where the impact is on the cells of immune system. MSCs exert regulatory effects on various cells of immune system such as dendritic cells, NK cells and T cells [10] [11] [12] . It is well established that MSCs lack the MHC class II molecule and hence do not mount an immune response; but instead they secrete cytokines such as prostaglandin E2 (PGE2), Interleukin 10 (IL-10), Interleukin 6 (IL-6), transforming growth factor β (TGFβ ), hepatocyte growth factor (HGF) etc. that are known to be involved in anti-inflammatory responses [13] [14] [15] . The effect of MSCs is seen on the maturation of antigen presenting cells, wherein they downregulate the expression of co-stimulatory molecules, thereby affecting the immunogenic response 12, 16 . These properties have been successfully used in graft versus host disease (GVHD) 17, 18 in many clinical trials along with other immune-related diseases. However, in all the studies reported, bone marrow-derived MSCs from allogenic sources are used and umbilical cord tissue-derived MSCs are now being introduced 19 . Studies with bone marrow and umbilical cord derived MSCs have looked into their immunosuppressive properties with a concomitant increase in the regulatory T cell fraction after MSC administration 20, 21 . But a source-dependent variation in the behaviour of MSCs has been observed. Here, we compared the immunomodulatory potential of MSCs derived from placenta and umbilical cord, obtained from the same individual.
Very few reports talk about the source dependent analysis of the effect of MSCs on the immune cells, where the comparison of sources is from different donors 22 . The donor variation in this context cannot be neglected suggesting a need to isolate MSCs from different sources obtained from the same donor 23 .
To study this effect, we co-cultured MSCs derived from human umbilical cord and placenta either with mononuclear cells or with dendritic cells. The effect mounted by this co-culture on the T cells in a mixed leukocyte reaction (MLR) was then assessed. We looked into the enrichment of any specific T cell subset in the MLR due to the presence of MSCs. We went on to examine the regulatory milieu by analyzing the cytokine profile of the MLRs.
We report here that P-MSCs bring about higher reduction in T cell proliferation in both types of MLRs compared to C-MSCs, and this is mainly due to the enrichment of regulatory T cell subset. A cell to cell contact is not necessary as even the CMs from the two types of MSCs showed a similar effect. Thus, by using paired samples -to minimize the sample variation and define the condition set of the isolated tissues -we show for the first time conclusively that there are striking differences in the two types of MSCs in their immunomodulatory behaviour. This study will help investigators to identify the proper source for MSCs in treatment of conditions like GVHD.
Results
Placenta-and umbilical cord-derived MSCs from paired samples showed similar phenotype, but different clonogenic ability. The MSCs derived from placenta and umbilical cord displayed typical fibroblastic morphology [ Fig. 1a ,b]. They also showed a similar marker expression profile, where they showed more than 90% expression for CD73, CD105, CD166, CD90, MHC class I molecule HLA ABC and were negative for expression of CD34, CD45, and MHC class II molecule HLA DR [ Fig. 1c,d ]. Due to the absence of MHC class II molecule, MSCs are reported to exhibit immunomodulatory abilities which grants these cells an advantage in transplantation settings 12 . Both the MSCs showed mesodermal lineage differentiation ability when subjected to adipocytic, osteocytic and chondrogenic differentiation as assessed by the Oil Red O staining, Alizarin Red S and Alcian blue staining respectively [ Supplementary  Fig. S1 ]. The clonogenic nature of a cell is defined by its ability to give rise to a colony of cells; this property is shown to be exhibited by MSCs which was assessed by the colony forming unit -fibroblast (CFU-F) assay. Plating of MSCs at different cell concentrations and then scoring for the number of colonies generated after 7-10 days showed that the clonogenic ability of P-MSCs and C-MSCs was different, though the tissues were isolated from the same individual. The colonies formed were assessed after 10 days by staining with crystal violet staining solution where the number of colonies in case of P-MSCs [ Fig. 1e ,g] were significantly more as compared to those in case of C-MSCs [ Fig. 1f,g ]. This suggests a higher expansion ability of P-MSCs. P-MSCs have higher immunosuppressive ability compared to C-MSCs. MSCs are known to have modulating effects on cells of the immune system. It has been reported that in co-cultures they hamper the antigen presenting ability of the cells thereby affecting the stimulation of T cells. Here, MSCs were seeded at different cell concentrations where the ratio of MSC:PB-MNCs (peripheral blood MNCs) was reduced. The co-culture was performed for 48 hrs and then 10 5 T cells were seeded at constant cell number in all wells. Both P-MSCs as well as C-MSCs were effective in reducing the T-cell proliferation. However, a significant reduction was evident only in P-MSCs at the lowest cell dose [ Fig. 2a ]. The reduction shown by P-MSCs was about 1.4 fold as compared to MNC control and 2.1 fold as compared to C-MSCs.
Placenta-and umbilical cord-derived MSCs differ in their ability to suppress the proliferation of T cells by dendritic cells. Dendritic cells (DCs) are excellent antigen presenting cells, which form an important mediator of innate and adaptive immune response and are capable of mounting an efficient T cell response for specific antigens. Dendritic cells were generated from human umbilical cord blood by a two-step culture method 24 . These DCs were characterized based on their morphology and marker expression profile [ Supplementary Fig. S2 ] prior to co-culture with MSCs. They showed typical 
Conditioned medium of MSCs contains immunosuppressive activity. MSCs derived from both
the sources affected the T cell proliferation ability of the antigen presenting cells in a co-culture system. So we wanted to see if similar kind of a difference is observed in case of cell free system i.e. by using conditioned medium (CM) of the MSCs. CM was prepared in plain medium over a confluent MSC culture and was collected after 48 hrs. 5 × 10 4 PB-MNCs or 5 × 10 3 or 10 4 dendritic cells were cultured in 50% MSC-CM in IMDM with 10% FCS. MNCs/DCs in IMDM + 10% FCS without CM were kept as controls. T cells were then added in equal numbers to assess whether the CM is also efficient in affecting the ability of the APCs to stimulate T cell proliferation. We observed that in comparison to cells grown in control medium, P-MSC-CM and C-MSC-CM showed significant reduction in T cell proliferation where the difference in the effect exerted by P-MSCs was significant as compared to C-MSCs [ Fig. 3a (MNCs) and b (DCs)]. Thus, cell-free extracts of both P-MSCs and C-MSCs also exert inhibitory effect on APCs thereby affecting the proliferation of T cells. We have observed the differences in the cytokine levels after keeping the cell numbers constant.
P-MSCs produce better regulatory cytokine profile in MLR.
A typical cytokine profile suggesting a regulatory phenotype involves the presence of IL-10 which leads to increase in pool of T regs. We measured the levels of IL-10, IFNγ and TGFβ 1 in culture supernatants of MLRs after T cell proliferation, by ELISA. A regulatory profile was observed in case of our MSC co-cultures where the levels of IL-10 were higher and those of IFNγ were less as compared to controls, and an anti-inflammatory condition was attained. We observed increased levels of IL-10 in MLRs of P-MSCs where they were co-cultured with PB-MNCs [ Fig. 4a ] as well as with DCs [ Fig. 4b ]. The increase was significant in case of P-MSCs in MSC MNC MLRs compared to controls. Though no significance was observed in MSC-DC-MLRs, the increase in P-MSCs was evident as opposed to C-MSCs. A concomitant decrease in levels of IFNγ was also observed. IFNγ levels decreased significantly in presence of P-/C-MSCs in both MSC-MNC [ P-MSCs have a more regulatory milieu that supports increase in T-reg population in co-cultures as compared to C-MSCs. In order to check whether there was enrichment of T regs (T regulatory) in MSC APC MLRS, we checked the T cells (Tc) for the co expression of CD4 and CD25. We characterized the proliferated T cells in the co-cultures after the MLRs. Flow cytometry analysis was carried out where the cells were gated on CD3 + T cell subset. In the CD3+ fraction, the CD4 positive cells were gated. The CD25 positive cells were then assessed in the CD4+ cell fraction. We found that in both MNCs and DCs co-cultured with MSCs there was an increase in the CD4 + CD25 + cells [Fig. 5a ,c]. The increase was apparent in case of P-MSCs as compared to C-MSCs in MSC MNC MLRs [ Fig. 5b ]. However, significant increase was found in P-MSC DC MLRs as compared to C-MSC DC MLRs [ Fig. 5d ]. These data suggest that the T cells attained a regulatory phenotype in case of MSC co-cultures. TGFβ -a cytokine implicated in the regulatory scenario was also assessed in P-and C-MSCs. Levels of TGFβ assessed by ELISA were significantly higher in P-MSC CM as compared to C-MSC CMs [ Fig. 6a ] and mRNA expression analysis reflected the same, showing higher expression in P-MSCs as compared to C-MSCs. [ Figure 6b ]. TGFβ 1 was also found to be increased in MSC-MNC-MLR CMs [ Fig. 6c ] with a significant difference observed in P-MSCs as opposed to C-MSCs, as well as in MSC-DC-MLR CMs as compared to control [ Fig. 6d ]. Thus, P-MSCs imparted a better regulatory milieu as compared to C-MSCs in an allogenic MLR. We further went on to assess the mRNA expression levels of FoxP3 associated with T regs. We extracted total RNA from the harvested MLRs and checked for the expression of FoxP3, which was found to be increased in the P-MSC -MLRs as well as C-MSC -MLRs compared to control [Fig. 6e,f] . This supports the hypothesis that P-MSCs have an enhanced ability of supporting a modulatory phenotype. 
Discussion
MSCs are known to exhibit immunomodulatory properties which have been utilized in many cellular aspects. Due to their immuno-suppressive nature, they are known to support graft survival 10 . In view of these benefits, along with their rapid expansion ability, they have been employed in many clinical trials (https://clinicaltrials.gov/). Though bone marrow is a reference standard for deriving MSCs, various other sources have been tapped for MSC isolation. Francisa Alcayaga-Martina et al. showed that menstrual fluid-derived MSCs were superior to BM-MSCs for HSC expansion 23 ; while others showed a comparison of MSCs from different sources derived from healthy and diseased individuals to assess their efficacy 25 . They found that control MSCs were able to ameliorate the disease in lupus-prone mice while the lupus patient derived MSCs could not. Our study aims to assess the differences in MSCs that are derived from placenta and umbilical cord procured from same donor i.e. a similar in vivo environment. Though the umbilical cord is of purely fetal origin, the placental tissue is derived partly from the mother and partly from the developing fetus.
In this study our focus was on comparison of MSCs derived from paired placenta and umbilical cord tissue. Both P-MSCs and C-MSCs showed typical fibroblastic morphology, phenotypic marker expression and mesodermal lineage differentiation ability thereby fulfilling the criteria for MSCs as directed by the International Society for Cell Therapy 26 . Difference was seen in the clonogenic ability where the P-MSCs were able to give rise to higher number of CFU-Fs as compared to C-MSCs suggesting a higher expansion ability of P-MSCs. Thus, there is an advantage of working with P-MSCs as they will give sizable number of cells for transplantation purposes. MSCs are implicated in modulating the immune system due to the absence of MHC class II molecule and co-stimulatory components such as CD80, CD86 and CD40. Dendritic cells (DCs) are important mediators of the innate and adaptive immune response capable of mounting an antigen-specific T cell response. Inhibition of the maturation and antigen-presenting functions of DCs derived from cord blood and monocytes by MSCs has been reported 27, 28 . The inefficient priming of antigen presenting cells (APCs) leads to a reduced T cell proliferation 10, 27 . When we assessed the immunomodulatory abilities of MSCs, we found that both P-MSCs as well as C-MSCs affected the proliferation of T-cells mediated by mononuclear cells as well as DCs. Though a difference in the decrease of T cell proliferation was not observed in MNC MLRs with higher cell numbers of P-MSCs and C-MSCs, we found a significant difference at the lowest concentration of P-MSCs suggesting that the P-MSCs in lower numbers would be still effective in their immunoregulatory property as compared to C-MSCs. The difference in case of P-MSCs and C-MSCs was significant in DC MLRs. The effect of MSCs is attributed to the cell to cell contact 29 as well as to the secreted factors such as PGE2, IDO, IL-10, TGFβ [30] [31] [32] [33] [34] . Our data showed that both contact cultures (MSC-APC co-cultures) as well as non-contact cultures (50% MSC conditioned medium) of both the MSCs resulted in reduced T cell proliferation by MNCs and DCs. In both the cases, P-MSCs emerged out to be superior in their immunomodulation ability. This might be attributed to the fact that P-MSCs are a heterogeneous population comprising of cells of both the maternal and fetal combination leading to an additive effect in the action 35 . However, the fetal and maternal proportion of cells in the growing culture needs to be looked into.
On one hand where the soluble factors of MSCs grant the DCs a tolerogenic phenotype 27 , on the other hand they lead to T reg induction by reducing interleukin 4 (IL-4) and interferon γ (IFNγ ) levels 28, 36, 37 . This is also associated with an increased IL-10 production imparting a regulatory phenotype to the T cells 36, 38 . A similar effect was observed in case of our MSC co-cultures where the levels of IL-10 and TGFβ were higher and those of IFNγ were less as compared to controls where an anti-inflammatory condition was attained. MSCs are involved in the increase of T regs after transplantations [39] [40] [41] . In agreement to the previous findings, we found an increase in the CD4 + CD25 + T cell subset, where the expression of FoxP3 was also increased.
With all the benefits associated with MSCs, identification of sources for isolating the cells superior in all respects is still an aspect of study. In this report, we put forth P-MSCs as an alternative to C-MSCs for transplantation in case of immunological ailments and allogenic transplantation where the risk of graft rejection is high. Both BM-MSCs and C-MSCs are currently employed in many clinical trials. In a report where MSCs from healthy BM and UC were used, UC-MSCs were more effective in suppressing the IFNγ production compared to BM-MSCs 25 . IFNγ reduction and increased IL-10 shifts the balance from a pro-inflammatory to an anti-inflammatory state which is necessary for a regulatory phenotype in cases of transplantation. Placental tissue can be obtained with an equivalent frequency as the umbilical cord, and hence can be cultured and expanded with ease. In the current study, we report a novel finding that P-MSCs are superior in terms of their expansion ability and immune regulatory properties to that of C-MSCs. Thus, our findings present P-MSCs as a better substitute to C-MSCs in cellular transplantation.
Materials and Methods
Ethical approval. All protocols and methods for collection and processing of human samples like placenta, umbilical cord, cord blood and peripheral blood were approved by National Centre for Cell Science Ethics Committee (NCCS-IEC) and NCCS Committee for Stem Cell Research (NCCS-IC-SCR), which is in accordance with the Declaration of Helsinki. Prior informed consent was taken from the volunteers. The format of consent forms was also approved by the NCCS-IEC and NCCS-IC-SCR. The experiments were performed in triplicates with cells from one donor (n = 3). 3 different paired samples were investigated to confirm the findings (N = 3).
MSCs from placenta and cord tissues. Placenta and umbilical cord were collected from full term deliveries. The protocol for MSC isolation is as described earlier 42 . Briefly, placenta and a piece of cord were washed in plain IMDM (Sigma Aldrich, St Louis, USA) and chopped mechanically. Enzymatic digestion was done and single cell suspension was further cultured in medium containing 20% mesenFBS (Gibco, Life Technologies, Grand Island, USA). MSCs were identified on the basis of their fibroblastic morphology and phenotypic characterization which was performed after passage 3 and was assessed by flow cytometry (BD Canto II, BD Biosciences). Single cell suspension of cells was made after trypsinizing the cells and staining for surface markers was done by performing dual staining using a panel of antibodies: CD105-PE + CD73-APC, CD166-PE + CD45-APC, HLA ABC-APC + HLA DR-PE and CD44-APC + CD34-PE. All antibodies were purchased from BD Pharmingen, CA, USA and CD90-APC and CD45-APC from eBioscience, San Diego, CA, USA. Mesodermal lineage differentiation towards the adipogenic, osteogenic and chondrogenic lineages was carried out using respective differentiation media (All from Gibco, Life Technologies, Grand Island, USA). The stains like oil red O, Alizarin red S and Alcian blue were used for identification of adipocytes, osteocytes and chondrocytes respectively after formaldehyde fixation (All stains were procured from Sigma Aldrich, St Louis, USA). DC generation from cord blood. DCs were expanded from cord blood derived mononuclear cells by a two step culture system established in our lab 24 . Briefly, MNCs were subjected to 1 hr plastic adherence to remove the monocytes. The non adherent population was cultured for expanding the CD34+ cells towards enrichment of DC progenitors using growth factors like Flt3L, SCF and TPO for 3 weeks. The cells were then subjected to differentiation using GM-CSF and IL3 for 3 days, GM-CSF and TNFα for 4 days. These cells were then pulsed with lipopolysaccharide for maturation. DCs were characterized on the basis of their morphology and by a panel of antibodies for positive marker expression like CD11c, CD83, CD80, CD86, CD1a, CD40, MHC class I and class II molecules by flow cytometry.
CFU-F assay. 5 In CM experiments, MNCs and DCs were cultured in 50% MSC-CMs for 48 hrs. All cultures were irradiated at 6400 rads prior to the addition of T cells. For an MLR, T cells were obtained from peripheral blood by using RosetteSep T cell enrichment cocktail (Stem Cell Technologies Inc., Vancouver, British Columbia, Canada) as per manufacturer's instructions. 10 5 T-cells were added to each well. Co-cultures without T cells were kept as negative controls. T cell proliferation was quantitated by 3H thymidine (BRIT, Mumbai) uptake assay.
Cytokine content analysis. Cytokine levels in supernatants of the MLRs were analysed by commercially available OptEIA ELISA kits for hIL-10, hIFNγ and hTGFβ 1 (purchased from BD Pharmingen, CA, USA) according to the manufacturer's instructions. The experiment was performed in triplicates with cells from one donor (n = 3) and 2 different paired samples [N = 2]. The P-and C-MSCs were seeded in equal numbers separately, co-cultured with equal numbers of MNCs or DCs for 48 hrs. The T-cells were also added at the same time point in equal numbers to all the wells.
Assessment of T-cell regulatory profile. T cells were collected from the cell suspensions of MLR, washed with PBS and incubated with antibodies against CD3-FITC, CD4-PE and CD25-APC for 45 min on ice. Cells were fixed and flow cytometric analysis was performed using BD FACS Canto II (BD Biosciences).
RNA isolation and Semi-quantitative PCR. Total RNA was prepared from T-cells using Trizol reagent (Invitrogen, USA). 1 μ g RNA was transcribed into cDNA using MMLV reverse transcriptase (Invitrogen, USA) and 150 ng of random primers (Invitrogen, USA). Primer sequences for GAPDH, FoxP3 and TGFβ are shown in Table 1 .
Statistical analysis. This was carried out using SigmaStat software by performing ANOVA. As multiple comparisons were done -ANOVA was used. All data are presented graphically with error bars as mean ± SEM, and P ≤ 0.05 was considered statistically significant.
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